Adagene Inc. (ADAG)

NASDAQ: ADAG · Real-Time Price · USD

1.990

+0.300 (17.75%)

Jan 22, 2026, 3:00 PM EST - Market open

Adagene Employees

Adagene had 138 employees as of December 31, 2024. The number of employees decreased by 36 or -20.69% compared to the previous year.

Employees

138

Change (1Y)

-36

Growth (1Y)

-20.69%

Revenue / Employee

$748

Profits / Employee

-$216,592

Market Cap

93.79M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	138	-36	-20.69%
Dec 31, 2023	174	-74	-29.84%
Dec 31, 2022	248	-11	-4.25%
Dec 31, 2021	259	61	30.81%
Dec 31, 2020	198	-	-

Related Stocks

Company Name	Employees
Pliant Therapeutics	171
Cibus	159
Adicet Bio	152
XBiotech	92
Immunic	91
ALX Oncology Holdings	44
Atossa Therapeutics	15
CalciMedica	14

Employee Rankings

ADAG News

5 weeks ago - Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126) - GlobeNewsWire
2 months ago - Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology - GlobeNewsWire
2 months ago - Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer - GlobeNewsWire
4 months ago - Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate - GlobeNewsWire
4 months ago - Adagene's ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China - GlobeNewsWire
5 months ago - Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor - GlobeNewsWire
5 months ago - Adagene to Participate in Two Investor Conferences in September - GlobeNewsWire
5 months ago - Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire